Search results for "Programmed cell death"

showing 10 items of 609 documents

Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide

2006

DNA double-strand breaks (DSBs) are potent killing lesions, and inefficient repair of DSBs does not only lead to cell death but also to genomic instability and tumorigenesis. DSBs are repaired by non-homologous end-joining and homologous recombination (HR). A key player in HR is Xrcc2, a Rad51-like protein. Cells deficient in Xrcc2 are hypersensitive to X-rays and mitomycin C and display increased chromosomal aberration frequencies. In order to elucidate the role of Xrcc2 in resistance to anticancer drugs, we compared Xrcc2 knockout (Xrcc2-/-) mouse embryonic fibroblasts with the corresponding isogenic wild-type and Xrcc2 complemented knockout cells. We show that Xrcc2-/- cells are hypersen…

MethylnitronitrosoguanidineCancer ResearchProgrammed cell deathDNA repairDNA damageMitomycinApoptosisBiologyNitrosourea Compoundschemistry.chemical_compoundOrganophosphorus CompoundsMafosfamideTemozolomidemedicineHumansCytotoxic T cellAntineoplastic Agents AlkylatingCyclophosphamideCisplatinMolecular biologyDNA-Binding ProteinsDacarbazineOncologychemistryApoptosisFotemustineCisplatinMutagensmedicine.drugCancer Letters
researchProduct

Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine

2006

Methylating drugs such as temozolomide (TMZ) are widely used in the treatment of brain tumours (malignant gliomas). The mechanism of TMZ-induced glioma cell death is unknown. Here, we show that malignant glioma cells undergo apoptosis following treatment with the methylating agents N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and TMZ. Cell death determined by colony formation and apoptosis following methylation is greatly stimulated by p53. Transfection experiments with O(6)-methylguanine-DNA methyltransferase (MGMT) and depletion of MGMT by O(6)-benzylguanine showed that, in gliomas, the apoptotic signal originates from O(6)-methylguanine (O(6)MeG) and that repair of O(6)MeG by MGMT prevent…

MethylnitronitrosoguanidineCancer ResearchProgrammed cell deathFas Ligand ProteinGuanineDNA repairFas-Associated Death Domain ProteinBlotting WesternApoptosisBiologymedicine.disease_causeO(6)-Methylguanine-DNA MethyltransferaseGliomaTemozolomideTumor Cells CulturedGeneticsmedicineHumansDNA Breaks Double-StrandedRNA Small InterferingAntineoplastic Agents AlkylatingneoplasmsMolecular BiologyTumor Stem Cell AssayCell ProliferationTemozolomideBrain NeoplasmsCell CycleGliomaCell cycleFlow CytometryFas receptormedicine.diseaseDacarbazineProto-Oncogene Proteins c-bcl-2ApoptosisCaspasesCancer researchTumor Suppressor Protein p53CarcinogenesisDNA Damagemedicine.drugOncogene
researchProduct

Approaches to study yeast cell aging and death

2014

For millennia, yeast has been exploited to obtain fermentation products, such as foods and beverages. For c. 50 years, yeast has been an established model organism for basic and applied research, and more specifically, for c. 15 years, this unicellular organism has been applied to dissect molecular mechanisms of cell aging and programmed cell death. In this review, we present an overview of approaches to study cell aging and death in yeast, including lifespan assessments, calorie restriction, cell viability, survival, and death markers.

Microbiological TechniquesProgrammed cell deathTime FactorsCell Deathved/biologyved/biology.organism_classification_rank.speciesCalorie restrictionSaccharomyces cerevisiaeMycologySaccharomyces cerevisiaeGeneral MedicineBiologybiology.organism_classificationApplied Microbiology and BiotechnologyMicrobiologyUnicellular organismYeastCell biologyyeast aging. chronological aging methods in yeast geneticsSettore BIO/13 - Biologia ApplicataViability assayModel organismCell agingFEMS Yeast Research
researchProduct

PD-L1 and PD-1 expression in thyroid follicular epithelial dysplasia : Hashimoto thyroiditis related atypia and potential papillary carcinoma precurs…

2022

Programmed cell death ligand (PD-L1)/PD-1 expression has been studied in a variety of cancers and blockage of PD-L1/PD-1 pathway is a cornerstone of immunotherapy. We studied PD-L1/PD-1 immunohistochemical expression in 47 thyroid gland specimens in groups of (1) Hashimoto thyroiditis (HT) only; (2) HT and follicular epithelial dysplasia (FED); and (3) HT, FED, and papillary thyroid carcinoma (PTC). PD-1 positivity was found in immune cells, namely in lymphocytes, macrophages, and plasma cells with mean values for lymphocytes and macrophages 9% in HT group, 4% in FED group, and 4% in PTC group. PD-L1 positivity was identified in both immune cells and in the normal epithelial cells. In the H…

Microbiology (medical)PD-L1Hashimoto thyroiditissyövän esiasteetthyroid glandendocrine system diseasesdysplasiatProgrammed Cell Death 1 ReceptorkilpirauhanenGeneral MedicineHashimoto Disease3121 Internal medicineB7-H1 AntigenCarcinoma PapillarykarsinoomatPathology and Forensic MedicineThyroid Cancer PapillaryimmuunijärjestelmäPD-1papillary thyroid carcinomaImmunology and AllergyHumansfollicular epithelial dysplasiaThyroid Neoplasms3111 Biomedicine
researchProduct

Astrocytes Protect Neurons from Aβ1-42 Peptide-Induced Neurotoxicity Increasing TFAM and PGC-1 and Decreasing PPAR-γ and SIRT-1

2015

One of the earliest neuropathological events in Alzheimer's disease is accumulation of astrocytes at sites of Aβ1-42 depositions. Our results indicate that Aβ1-42 toxic peptide increases lipid peroxidation, apoptosis and cell death in neurons but not in astrocytes in primary culture. Aβ1-42-induced deleterious neuronal effects are not present when neurons and astrocytes are mixed cultured. Stimulation of astrocytes with toxic Aβ1-42 peptide increased p-65 and decreased IκB resulting in inflammatory process. In astrocytes Aβ1-42 decreases protein expressions of sirtuin 1 (SIRT-1) and peroxisome proliferator-activated receptor γ (PPAR-γ) and over-expresses peroxisome proliferator-activated re…

MnSODProgrammed cell deathPPAR-γPeroxisome proliferator-activated receptorMitochondrionBiologyBioinformaticsmedicine.disease_causeAlzheimer's DiseaseNeurologiaPGC-1Sirtuin 1medicineAnimalsTFAMCells Culturedchemistry.chemical_classificationNeuronsAmyloid beta-PeptidesCell DeathSirtuin 1Caspase 3Superoxide DismutaseNeurotoxicityTranscription Factor RelAGeneral MedicineTFAMmedicine.diseasePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaCoculture TechniquesPeptide FragmentsCell biologyMitochondriaPeroxidesRatsPPAR gammachemistryMitochondrial biogenesisNF-κB.Astrocytesbiology.proteinFisiologia humanaLipid PeroxidationOxidative stressResearch PaperTranscription FactorsInternational Journal of Medical Sciences
researchProduct

In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators

2008

One of the major problems in the fight against cancer is drug-resistance, which, at a molecular level, can be acquired through mutations able to deactivate apoptosis. In particular, proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-xl and Bcl-2, are overexpressed in many tumours. The development of new inhibitors of these proteins as potential anticancer therapeutics represents a new frontier. In this work, we carried out an in-silico screening of compounds from a free database of more than 2 million structures (ZINC database), which allowed us to identify 17 sulfonamide derivatives as new potential inhibitors; thes…

Models MolecularProgrammed cell deathDatabases FactualIn silicobcl-X ProteinAntineoplastic AgentsApoptosisBcl-xLDrug resistanceBiologyCatalysisInorganic ChemistryNeoplasmsmedicineAnimalsHumansPhysical and Theoretical ChemistryOrganic ChemistrySulfonamide (medicine)CancerApoptosis Bcl-2 Bcl-xl Inhibitors Molecular dockingmedicine.diseaseSettore CHIM/08 - Chimica FarmaceuticaMolecular medicineComputer Science ApplicationsCell biologyComputational Theory and MathematicsDrug Resistance NeoplasmApoptosisCancer researchbiology.proteinDrug Screening Assays Antitumormedicine.drugJournal of Molecular Modeling
researchProduct

Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells

2013

International audience; Bleomycin (BLM) is an anticancer drug currently used for the treatment of testis cancer and Hodgkin lymphoma. This drug triggers cancer cell death via its capacity to generate radical oxygen species (ROS). However, the putative contribution of anticancer immune responses to the efficacy of BLM has not been evaluated. We make here the observation that BLM induces immunogenic cell death. In particular, BLM is able to induce ROS-mediated reticulum stress and autophagy, which result in the surface exposure of chaperones, including calreticulin and ERp57, and liberation of HMBG1 and ATP. BLM induces anti-tumor immunity which relies on calreticulin, CD8(+) T cells and inte…

MouseCancer TreatmentCD8-Positive T-LymphocytesT-Lymphocytes RegulatoryHematologic Cancers and Related DisordersMice0302 clinical medicineTransforming Growth Factor beta[ SDV.IMM ] Life Sciences [q-bio]/ImmunologyCytotoxic T cellImmune Response0303 health sciencesMultidisciplinaryCell DeathbiologyQRFOXP3Animal ModelsHematology3. Good healthCell biologyOncology030220 oncology & carcinogenesisMedicine[SDV.IMM]Life Sciences [q-bio]/ImmunologyImmunogenic cell deathFemaleLymphomasOncology AgentsResearch ArticleTumor Immunologycongenital hereditary and neonatal diseases and abnormalitiesProgrammed cell death[SDV.IMM] Life Sciences [q-bio]/ImmunologyScienceImmunologyAntineoplastic Agentschemical and pharmacologic phenomenaBleomycin03 medical and health sciencesModel OrganismsImmune systemCell Line TumorAnimalsHumansBiologyCell Proliferation030304 developmental biologyHodgkin Lymphomaurogenital systemCell growthImmunitynutritional and metabolic diseasesImmunologic SubspecialtiesChemotherapy and Drug TreatmentImmunity InnateCancer cellbiology.proteinClinical ImmunologyCalreticulinPLoS ONE
researchProduct

Degeneration of moulting glands in male crickets

1998

The degeneration of the prothoracic glands of the male cricket, Gryllus bimaculatus, was analyzed by using an in vitro assay for ecdysteroid release from the moulting glands in last instar nymphs as well as in adult animals, and correlated with light and transmission electron microscopy. Apoptosis was examined by the TUNEL-reaction. The ability to synthesize ecdysteroids reached a peak at the 8th day of the last larval instar, identified as the moulting peak. After adult ecdysis it decreased to barely measurable values. Prothoracic gland degeneration was initiated at the time of the moulting peak, characterized by TUNEL positive reactions, nuclear and cytoplasmatic condensation, a striking …

Mudamedicine.medical_specialtyEcdysteroidProgrammed cell deathbiologyPhysiologyGryllus bimaculatusfungibiology.organism_classificationProthoracic glandchemistry.chemical_compoundEndocrinologychemistryInsect ScienceEcdysisInternal medicinemedicineInstarMoultingJournal of Insect Physiology
researchProduct

Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated au…

2012

AbstractAntineutrophil cytoplasmic antibodies (ANCAs) target proteins normally retained within neutrophils, indicating that cell death is involved in the autoimmunity process. Still, ANCA pathogenesis remains obscure. ANCAs activate neutrophils inducing their respiratory burst and a peculiar form of cell death, named NETosis, characterized by formation of neutrophil extracellular traps (NETs), decondensed chromatin threads decorated with cytoplasmic proteins endorsed with antimicrobial activity. NETs have been consistently detected in ANCA-associated small-vessel vasculitis, and this association prompted us to test whether the peculiar structure of NET favors neutrophil proteins uploading i…

MyeloidNeutrophilsApoptosisAutoimmunitymedicine.disease_causeAutoantigensBiochemistryAutoimmunityImmunoenzyme TechniquesMiceCytosolMyeloid CellsSkinMice Inbred BALB CReverse Transcriptase Polymerase Chain ReactionANCACell DifferentiationHematologyFlow CytometryAcquired immune systemCell biologyRespiratory burstmedicine.anatomical_structureFemaleANCA; Neutrophil extracellular traps; myeloid dendritic cells; autoimmunity.Programmed cell deathBlotting WesternImmunologyautoimmunity.Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisEnzyme-Linked Immunosorbent AssayBiologyReal-Time Polymerase Chain ReactionAntibodies Antineutrophil CytoplasmicAntigenmedicineAnimalsHumansRNA Messengercardiovascular diseasesCell ProliferationAnti-neutrophil cytoplasmic antibodyDendritic CellsCell BiologyNeutrophil extracellular trapsmyeloid dendritic cellMice Inbred C57BLImmunologyImmunizationNeutrophil extracellular trap
researchProduct

2015

The NG2 proteoglycan is characteristically expressed by oligodendrocyte progenitor cells (OPC) and also by aggressive brain tumours highly resistant to chemo- and radiation therapy. Oligodendrocyte-lineage cells are particularly sensitive to stress resulting in cell death in white matter after hypoxic or ischemic insults of premature infants and destruction of OPC in some types of Multiple Sclerosis lesions. Here we show that the NG2 proteoglycan binds OMI/HtrA2, a mitochondrial serine protease which is released from damaged mitochondria into the cytosol in response to stress. In the cytosol, OMI/HtrA2 initiates apoptosis by proteolytic degradation of anti-apoptotic factors. OPC in which NG…

NG2 proteoglycanSmall interfering RNAProgrammed cell deathMultidisciplinaryTransfectionMitochondrionBiologymedicine.disease_causeMolecular biologyCell biologynervous systemCell cultureApoptosismedicineOxidative stressPLOS ONE
researchProduct